Index S&P 500
P/E 17.06
EPS (ttm) 7.72
Insider Own 0.67%
Shs Outstand 1.73B
Perf Week 2.95%
Market Cap 228.46B
Forward P/E 23.19
EPS next Y 5.68
Insider Trans -6.10%
Shs Float 1.72B
Perf Month 4.27%
Income 13.46B
PEG 1.65
EPS next Q 1.25
Inst Own 78.92%
Short Float 1.27%
Perf Quarter 12.79%
Sales 42.34B
P/S 5.40
EPS this Y 10.45%
Inst Trans 2.75%
Short Ratio 2.87
Perf Half Y 11.74%
Book/sh 27.52
P/B 4.79
EPS next Y 10.13%
ROA 17.27%
Short Interest 21.79M
Perf Year 25.14%
Cash/sh 4.59
P/C 28.68
EPS next 5Y 10.34%
ROE 30.96%
52W Range 99.71 - 141.23
Perf YTD 16.46%
Dividend Est. 2.37 (1.80%)
P/FCF 35.97
EPS past 5Y 29.98%
ROI 21.99%
52W High -6.73%
Beta 0.71
Dividend TTM 2.28 (1.73%)
Quick Ratio 1.23
Sales past 5Y 6.15%
Gross Margin 58.23%
52W Low 32.11%
ATR (14) 3.74
Dividend Ex-Date Apr 15, 2025
Current Ratio 1.67
EPS Y/Y TTM 134.50%
Oper. Margin 17.10%
RSI (14) 56.02
Volatility 2.59% 3.01%
Employees 114000
Debt/Eq 0.32
Sales Y/Y TTM 5.00%
Profit Margin 31.78%
Recom 1.83
Target Price 142.90
Option/Short Yes / Yes
LT Debt/Eq 0.28
EPS Q/Q 8.76%
Payout 29.33%
Rel Volume 0.77
Prev Close 129.89
Sales Surprise -0.46%
EPS Surprise 1.66%
Sales Q/Q 3.95%
Earnings Apr 16 BMO
Avg Volume 7.60M
Price 131.73
SMA20 2.50%
SMA50 0.66%
SMA200 11.32%
Trades
Volume 5,831,808
Change 1.42%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-08-24 Initiated
Oppenheimer
Outperform
$130
Sep-19-24 Initiated
Piper Sandler
Overweight
$131
Jul-30-24 Downgrade
Edward Jones
Buy → Hold
May-30-24 Initiated
Goldman
Buy
$121
Jul-21-23 Upgrade
Wolfe Research
Underperform → Peer Perform
May-30-23 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$112
Apr-20-23 Reiterated
Wolfe Research
Underperform
$107 → $103
Apr-20-23 Reiterated
UBS
Buy
$117 → $130
Apr-20-23 Reiterated
Raymond James
Outperform
$116 → $123
Apr-20-23 Reiterated
JP Morgan
Overweight
$118 → $122
Apr-20-23 Reiterated
Bernstein
Outperform
$132 → $133
Apr-20-23 Reiterated
Barclays
Overweight
$125 → $127
Mar-29-23 Initiated
UBS
Buy
$117
Oct-26-22 Initiated
Mizuho
Neutral
$105
Oct-18-22 Initiated
Barclays
Overweight
$118
Oct-12-22 Initiated
Jefferies
Hold
$110
Jul-06-22 Initiated
Wolfe Research
Underperform
$95
Mar-02-22 Resumed
BofA Securities
Buy
$140
Jan-27-22 Reiterated
UBS
Buy
$138 → $142
Jan-27-22 Reiterated
Raymond James
Outperform
$150 → $143
Show Previous Ratings
Apr-19-25 12:06PM
09:54AM
Apr-18-25 02:03PM
Apr-17-25 02:00PM
12:05PM
11:50AM
Loading…
11:50AM
10:00AM
09:41AM
08:20AM
07:37AM
06:20AM
03:10AM
03:01AM
01:08AM
(Thomson Reuters StreetEvents)
Apr-16-25 04:56PM
04:45PM
Loading…
04:45PM
04:10PM
04:04PM
(Investor's Business Daily)
03:57PM
03:49PM
03:01PM
02:41PM
02:11PM
01:07PM
12:20PM
(The Wall Street Journal)
12:18PM
12:12PM
12:03PM
11:55AM
11:24AM
11:19AM
Loading…
11:19AM
(The Wall Street Journal)
10:54AM
10:53AM
10:28AM
10:17AM
09:44AM
09:30AM
09:21AM
08:59AM
(Investor's Business Daily)
08:59AM
(Investor's Business Daily)
08:45AM
08:43AM
08:23AM
(The Wall Street Journal)
08:15AM
07:43AM
07:38AM
(Associated Press Finance)
07:33AM
07:32AM
07:30AM
Apr-15-25 03:02PM
09:28AM
08:39AM
08:35AM
08:00AM
Apr-14-25 08:42PM
03:00PM
12:18PM
09:48AM
08:24AM
06:20AM
Apr-13-25 09:37AM
06:00AM
Apr-12-25 11:00AM
01:27AM
Apr-11-25 10:01AM
09:15AM
Apr-10-25 05:50PM
09:34AM
(Investor's Business Daily)
08:52AM
07:25AM
07:16AM
06:15AM
02:37AM
Apr-09-25 03:00PM
10:00AM
09:52AM
09:00AM
08:47AM
06:33AM
Apr-08-25 12:04PM
09:46AM
06:20AM
06:13AM
Apr-07-25 02:24PM
08:48AM
08:14AM
Apr-06-25 08:54AM
Apr-05-25 03:40AM
Apr-04-25 12:42PM
09:30AM
08:09AM
06:51AM
05:01AM
Apr-03-25 05:57PM
05:50PM
02:22PM
01:25PM
Apr-02-25 09:40AM
08:50AM
Apr-01-25 08:27AM
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Earnhardt Lisa D EVP AND GROUP PRESIDENT Mar 06 '25 Option Exercise 80.98 91,167 7,382,704 163,095 Mar 07 06:55 PM Earnhardt Lisa D EVP AND GROUP PRESIDENT Mar 07 '25 Option Exercise 80.98 200 16,196 72,128 Mar 07 06:55 PM Earnhardt Lisa D EVP AND GROUP PRESIDENT Mar 06 '25 Sale 133.82 91,167 12,199,968 71,928 Mar 07 06:55 PM Earnhardt Lisa D EVP AND GROUP PRESIDENT Mar 07 '25 Sale 136.65 200 27,329 71,928 Mar 07 06:55 PM Lisa D. Earnhardt Officer Mar 07 '25 Proposed Sale 136.65 200 27,329 Mar 07 06:28 PM Lisa D. Earnhardt Officer Mar 06 '25 Proposed Sale 133.82 91,167 12,199,967 Mar 06 05:47 PM Wainer Andrea F RETIRED EVP Mar 03 '25 Sale 138.17 949 131,123 74,381 Mar 04 08:05 PM Shroff Eric Senior Vice President Mar 03 '25 Sale 138.17 562 77,652 31,970 Mar 04 08:00 PM Morrone Louis H. EXECUTIVE VICE PRESIDENT Mar 03 '25 Sale 138.17 1,111 153,507 66,878 Mar 04 07:49 PM Moreland Mary K EXECUTIVE VICE PRESIDENT Mar 03 '25 Sale 138.17 791 109,292 95,583 Mar 04 07:44 PM MCCOY JOHN A. JR. VICE PRESIDENT AND CONTROLLER Mar 03 '25 Sale 138.17 562 77,652 21,061 Mar 04 07:39 PM Eric Shroff Officer Mar 03 '25 Proposed Sale 138.17 562 77,651 Mar 03 08:40 PM Andrea F. Wainer Retired Officer Mar 03 '25 Proposed Sale 138.17 949 131,123 Mar 03 08:18 PM Louis H. Morrone Officer Mar 03 '25 Proposed Sale 138.17 1,111 153,506 Mar 03 08:08 PM Mary K. Moreland Officer Mar 03 '25 Proposed Sale 138.17 791 109,292 Mar 03 07:58 PM John A. McCoy, Jr. Officer Mar 03 '25 Proposed Sale 138.17 562 77,651 Mar 03 07:52 PM Ford Robert B CHAIRMAN AND CEO Feb 05 '25 Option Exercise 38.40 285,388 10,958,899 505,447 Feb 07 05:51 PM Ford Robert B CHAIRMAN AND CEO Feb 05 '25 Sale 131.17 285,388 37,435,200 220,059 Feb 07 05:51 PM Robert B. Ford Officer Feb 05 '25 Proposed Sale 131.17 285,388 37,435,238 Feb 05 06:52 PM ALLEN HUBERT L EXECUTIVE VICE PRESIDENT Jan 29 '25 Option Exercise 38.40 131,360 5,044,224 316,166 Jan 31 07:16 PM ALLEN HUBERT L EXECUTIVE VICE PRESIDENT Jan 30 '25 Option Exercise 38.40 58,428 2,243,635 243,234 Jan 31 07:16 PM ALLEN HUBERT L EXECUTIVE VICE PRESIDENT Jan 29 '25 Sale 128.35 131,360 16,859,675 184,806 Jan 31 07:16 PM ALLEN HUBERT L EXECUTIVE VICE PRESIDENT Jan 30 '25 Sale 128.07 58,428 7,482,629 184,806 Jan 31 07:16 PM Salvadori Daniel Gesua Sive EXECUTIVE VICE PRESIDENT Jan 30 '25 Option Exercise 38.40 23,771 912,806 149,468 Jan 31 07:08 PM Salvadori Daniel Gesua Sive EXECUTIVE VICE PRESIDENT Jan 30 '25 Sale 128.50 23,771 3,054,574 125,697 Jan 31 07:08 PM Morrone Louis H. EXECUTIVE VICE PRESIDENT Jan 28 '25 Sale 127.39 2,644 336,819 0 Jan 30 07:33 PM Hubert L. Allen Officer Jan 30 '25 Proposed Sale 128.07 58,428 7,482,628 Jan 30 05:33 PM Daniel Gesua Sive Salvadori Officer Jan 30 '25 Proposed Sale 128.50 23,771 3,054,573 Jan 30 05:26 PM Hubert L. Allen Officer Jan 29 '25 Proposed Sale 128.35 131,360 16,859,675 Jan 29 05:30 PM Funck, Jr. Robert E. Officer Nov 04 '24 Proposed Sale 120.00 15,000 1,800,000 Nov 04 04:02 PM ALLEN HUBERT L EXECUTIVE VICE PRESIDENT Oct 21 '24 Option Exercise 47.00 157,421 7,398,787 342,227 Oct 23 05:10 PM ALLEN HUBERT L EXECUTIVE VICE PRESIDENT Oct 21 '24 Sale 117.04 157,421 18,424,298 184,806 Oct 23 05:10 PM ALLEN HUBERT L Officer Oct 21 '24 Proposed Sale 118.89 157,421 18,715,783 Oct 21 04:08 PM Ford Robert B CHAIRMAN AND CEO Sep 12 '24 Option Exercise 47.19 141,679 6,685,975 361,738 Sep 13 05:24 PM Ford Robert B CHAIRMAN AND CEO Sep 12 '24 Sale 116.41 141,679 16,493,218 220,059 Sep 13 05:24 PM Robert B. Ford Officer Sep 12 '24 Proposed Sale 116.41 141,679 16,492,852 Sep 12 06:20 PM MCCOY JOHN A. JR. VICE PRESIDENT Sep 04 '24 Sale 114.83 27 3,100 18,681 Sep 04 07:52 PM Funck, Jr. Robert E. Officer Sep 04 '24 Proposed Sale 115.00 30,000 3,450,000 Sep 04 04:04 PM Funck, Jr. Robert E. EXECUTIVE VICE PRESIDENT May 10 '24 Option Exercise 47.00 10,097 474,559 221,438 May 14 05:35 PM Funck, Jr. Robert E. EXECUTIVE VICE PRESIDENT May 10 '24 Sale 104.57 10,097 1,055,819 211,341 May 14 05:35 PM Earnhardt Lisa D EXECUTIVE VICE PRESIDENT May 07 '24 Sale 106.25 22,852 2,428,119 61,462 May 08 05:00 PM